Enctr for prphylc immther for resp syncytial virus (RSV)

This code signifies an encounter where a patient receives preventative treatment against Respiratory Syncytial Virus (RSV) through immunotherapy. This typically involves the administration of monoclonal antibodies to provide passive immunity, rather than stimulating the body's own immune response.

Use this code for encounters where an infant or high-risk individual is receiving prophylactic injections, such as palivizumab, to prevent severe RSV infection. It is appropriate for routine scheduled administrations of these preventative agents.

• Do not use this code for active RSV infection or for general immunization encounters.
• Always code the administration procedure separately.
• Consider any relevant patient risk factors (e.g., prematurity, chronic lung disease) that may also need to be coded.